CN Patent

CN105636630B — 干粉吸入器

Assigned to Teva Branded Pharmaceutical Products R&D Inc · Expires 2020-05-19 · 6y expired

What this patent protects

本发明提供干粉吸入器，其包含：包含丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中每次驱动的沙美特罗的递送剂量低于50μg；且其中该剂量在接受该剂量的30分钟内给患者提供超过150mL的基线调整的FEV 1 。治疗患者的方法包括给患者施用具有丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中每次驱动的沙美特罗的递送剂量低于50μg；并且在接受该剂量的30分钟内给患者提供超过150mL的基线调整的FEV 1 。

USPTO Abstract

本发明提供干粉吸入器，其包含：包含丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中每次驱动的沙美特罗的递送剂量低于50μg；且其中该剂量在接受该剂量的30分钟内给患者提供超过150mL的基线调整的FEV 1 。治疗患者的方法包括给患者施用具有丙酸氟替卡松、昔萘酸沙美特罗和乳糖载体的干粉药物；其中每次驱动的沙美特罗的递送剂量低于50μg；并且在接受该剂量的30分钟内给患者提供超过150mL的基线调整的FEV 1 。

Drugs covered by this patent

Patent Metadata

Patent number
CN105636630B
Jurisdiction
CN
Classification
—
Expires
2020-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Teva Branded Pharmaceutical Products R&D Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.